Article Cited by others

MOLECULES OF MILLENNIUM

Lifitegrast: A novel drug for treatment of dry eye disease

Abidi Afroz, Shukla Pooja, Ahmad Ali

Year : 2016| Volume: 7| Issue : 4 | Page no: 194-198

   This article has been cited by
 
1 Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease
Edward J. Holland, Mitchell A. Jackson, Eric Donnenfeld, Rebecca Piccolo, Alisa Cohen, Stefano Barabino, Maurizio Rolando, Francisco C. Figueiredo
JAMA Ophthalmology. 2021; 139(11): 1200
[Pubmed]  [Google Scholar] [DOI]
2 The role of Th17 immunity in chronic ocular surface disorders
Nai-Wen Fan, Thomas H. Dohlman, William Foulsham, Matthew McSoley, Rohan Bir Singh, Yihe Chen, Reza Dana
The Ocular Surface. 2021; 19: 157
[Pubmed]  [Google Scholar] [DOI]
3 U.S. FDA Approved Drugs from 2015–June 2020: A Perspective
Priyadeep Bhutani, Gaurav Joshi, Nivethitha Raja, Namrata Bachhav, Prabhakar K. Rajanna, Hemant Bhutani, Atish T. Paul, Raj Kumar
Journal of Medicinal Chemistry. 2021; 64(5): 2339
[Pubmed]  [Google Scholar] [DOI]
4 Real-world experience of using ciclosporin-A 0.1% (Ikervis) in the management of ocular surface inflammatory diseases
Rashmi Deshmukh, Darren Shu Jeng Ting, Ahmad Elsahn, Imran Mohammed, Dalia G Said, Harminder Singh Dua
British Journal of Ophthalmology. 2021; : bjophthalm
[Pubmed]  [Google Scholar] [DOI]
5 Evidence of Polyphenols Efficacy against Dry Eye Disease
Gaia Favero, Enrico Moretti, Kristína Krajcíková, Vladimíra Tomecková, Rita Rezzani
Antioxidants. 2021; 10(2): 190
[Pubmed]  [Google Scholar] [DOI]
6 Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered
Gysbert-Botho van Setten
International Journal of Molecular Sciences. 2020; 21(12): 4333
[Pubmed]  [Google Scholar] [DOI]
7 Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA
José Antonio Encinar, Javier A. Menendez
Viruses. 2020; 12(5): 525
[Pubmed]  [Google Scholar] [DOI]
8 30 Years of Biotherapeutics Development—What Have We Learned?
Nico Ghilardi, Rajita Pappu, Joseph R. Arron, Andrew C. Chan
Annual Review of Immunology. 2020; 38(1): 249
[Pubmed]  [Google Scholar] [DOI]
9

A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca

Gary W Jerkins, Guruprasad R Pattar, Shane R Kannarr
Clinical Ophthalmology. 2020; Volume 14: 481
[Pubmed]  [Google Scholar] [DOI]
10

Ocular Neuropathic Pain: An Overview Focusing on Ocular Surface Pains

Nazanin Ebrahimiadib, Fardin Yousefshahi, Parisa Abdi, Mohammadreza Ghahari, Bobeck S Modjtahedi
Clinical Ophthalmology. 2020; Volume 14: 2843
[Pubmed]  [Google Scholar] [DOI]
11

A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments

Laura M Periman, Francis S Mah, Paul M Karpecki
Clinical Ophthalmology. 2020; Volume 14: 4187
[Pubmed]  [Google Scholar] [DOI]
12 The Role of Nano-ophthalmology in Treating Dry Eye Disease
Subramanian Natesan, Sai H.S. Boddu, Venkateshwaran Krishnaswami, Moyad Shahwan
Pharmaceutical Nanotechnology. 2020; 8(4): 258
[Pubmed]  [Google Scholar] [DOI]
13 Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye
Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, Jing-Ping Liou
Journal of Medicinal Chemistry. 2020; 63(19): 10533
[Pubmed]  [Google Scholar] [DOI]
14 An Efficient and Scalable Synthesis of Lifitegrast
Jayaprakash Rao Yerrabelly, Rajashekar Kommera, Venkateshwer Reddy Kasireddy, Venkat Reddy Ghojala, Hemasri Yerrabelly
ChemistrySelect. 2020; 5(11): 3355
[Pubmed]  [Google Scholar] [DOI]
15 Current and Future Pharmacological Therapies for the Management of Dry Eye
Preeya K. Gupta, Penny Asbell, John Sheppard
Eye & Contact Lens: Science & Clinical Practice. 2020; 46(2): S64
[Pubmed]  [Google Scholar] [DOI]
16 ICAM3 mediates tumor metastasis via a LFA-1-ICAM3-ERM dependent manner
Wenzhi Shen,Xiaoyuan Zhang,Renle Du,Yan Fan,Dehong Luo,Yonghua Bao,Wancai Yang,Na Luo,Yunping Luo,Shuangtao Zhao
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 Synthetic Approaches to New Drugs Approved During 2016
Andrew C. Flick,Hong X. Ding,Carolyn A. Leverett,Sarah J. Fink,Christopher J. O’Donnell
Journal of Medicinal Chemistry. 2018;
[Pubmed]  [Google Scholar] [DOI]
18 Therapeutic inhibitors for the treatment of dry eye syndrome
Candela Rodríguez-Pomar,Jesus Pintor,Basilio Colligris,Gonzalo Carracedo
Expert Opinion on Pharmacotherapy. 2017; 18(17): 1855
[Pubmed]  [Google Scholar] [DOI]
19 Neuropathic Corneal Pain
Gabriela Dieckmann,Sunali Goyal,Pedram Hamrah
Ophthalmology. 2017; 124(11): S34
[Pubmed]  [Google Scholar] [DOI]
20 The role of lipids in corneal diseases and dystrophies: a systematic review
Tyler G. Rowsey,Dimitrios Karamichos
Clinical and Translational Medicine. 2017; 6(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article